Medical Care

Global T-Cell Therapy Market Research Report 2025

The global market for T-Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for T-Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for T-Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for T-Cell Therapy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of T-Cell Therapy include Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc., Pfizer Inc., DiaCarta, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell Therapy.
The T-Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global T-Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the T-Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences, Inc.
Sorrento Therapeutics
Fate Therapeutics Inc.
Novartis International AG
AbbVie Inc.
Adaptimmune Therapeutics PLC
Bluebird Bio
TCR2 Therapeutics, Inc.
Pfizer Inc.
DiaCarta, Inc.
Segment by Type
CAR T Cell Therapy
TCR Therapy
TIL Therapy
Segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of T-Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CAR T Cell Therapy
1.2.3 TCR Therapy
1.2.4 TIL Therapy
1.3 Market by Application
1.3.1 Global T-Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global T-Cell Therapy Market Perspective (2020-2031)
2.2 Global T-Cell Therapy Growth Trends by Region
2.2.1 Global T-Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 T-Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 T-Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 T-Cell Therapy Market Dynamics
2.3.1 T-Cell Therapy Industry Trends
2.3.2 T-Cell Therapy Market Drivers
2.3.3 T-Cell Therapy Market Challenges
2.3.4 T-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top T-Cell Therapy Players by Revenue
3.1.1 Global Top T-Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by T-Cell Therapy Revenue
3.4 Global T-Cell Therapy Market Concentration Ratio
3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2024
3.5 Global Key Players of T-Cell Therapy Head office and Area Served
3.6 Global Key Players of T-Cell Therapy, Product and Application
3.7 Global Key Players of T-Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 T-Cell Therapy Breakdown Data by Type
4.1 Global T-Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global T-Cell Therapy Forecasted Market Size by Type (2026-2031)
5 T-Cell Therapy Breakdown Data by Application
5.1 Global T-Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global T-Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America T-Cell Therapy Market Size (2020-2031)
6.2 North America T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America T-Cell Therapy Market Size by Country (2020-2025)
6.4 North America T-Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe T-Cell Therapy Market Size (2020-2031)
7.2 Europe T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe T-Cell Therapy Market Size by Country (2020-2025)
7.4 Europe T-Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific T-Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific T-Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific T-Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific T-Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America T-Cell Therapy Market Size (2020-2031)
9.2 Latin America T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America T-Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America T-Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa T-Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa T-Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa T-Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Details
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. T-Cell Therapy Introduction
11.1.4 Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2020-2025)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 Sorrento Therapeutics
11.2.1 Sorrento Therapeutics Company Details
11.2.2 Sorrento Therapeutics Business Overview
11.2.3 Sorrento Therapeutics T-Cell Therapy Introduction
11.2.4 Sorrento Therapeutics Revenue in T-Cell Therapy Business (2020-2025)
11.2.5 Sorrento Therapeutics Recent Development
11.3 Fate Therapeutics Inc.
11.3.1 Fate Therapeutics Inc. Company Details
11.3.2 Fate Therapeutics Inc. Business Overview
11.3.3 Fate Therapeutics Inc. T-Cell Therapy Introduction
11.3.4 Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2020-2025)
11.3.5 Fate Therapeutics Inc. Recent Development
11.4 Novartis International AG
11.4.1 Novartis International AG Company Details
11.4.2 Novartis International AG Business Overview
11.4.3 Novartis International AG T-Cell Therapy Introduction
11.4.4 Novartis International AG Revenue in T-Cell Therapy Business (2020-2025)
11.4.5 Novartis International AG Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Details
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. T-Cell Therapy Introduction
11.5.4 AbbVie Inc. Revenue in T-Cell Therapy Business (2020-2025)
11.5.5 AbbVie Inc. Recent Development
11.6 Adaptimmune Therapeutics PLC
11.6.1 Adaptimmune Therapeutics PLC Company Details
11.6.2 Adaptimmune Therapeutics PLC Business Overview
11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Introduction
11.6.4 Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2020-2025)
11.6.5 Adaptimmune Therapeutics PLC Recent Development
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Details
11.7.2 Bluebird Bio Business Overview
11.7.3 Bluebird Bio T-Cell Therapy Introduction
11.7.4 Bluebird Bio Revenue in T-Cell Therapy Business (2020-2025)
11.7.5 Bluebird Bio Recent Development
11.8 TCR2 Therapeutics, Inc.
11.8.1 TCR2 Therapeutics, Inc. Company Details
11.8.2 TCR2 Therapeutics, Inc. Business Overview
11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Introduction
11.8.4 TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2020-2025)
11.8.5 TCR2 Therapeutics, Inc. Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. T-Cell Therapy Introduction
11.9.4 Pfizer Inc. Revenue in T-Cell Therapy Business (2020-2025)
11.9.5 Pfizer Inc. Recent Development
11.10 DiaCarta, Inc.
11.10.1 DiaCarta, Inc. Company Details
11.10.2 DiaCarta, Inc. Business Overview
11.10.3 DiaCarta, Inc. T-Cell Therapy Introduction
11.10.4 DiaCarta, Inc. Revenue in T-Cell Therapy Business (2020-2025)
11.10.5 DiaCarta, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CAR T Cell Therapy
Table 3. Key Players of TCR Therapy
Table 4. Key Players of TIL Therapy
Table 5. Global T-Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global T-Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global T-Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global T-Cell Therapy Market Share by Region (2020-2025)
Table 9. Global T-Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global T-Cell Therapy Market Share by Region (2026-2031)
Table 11. T-Cell Therapy Market Trends
Table 12. T-Cell Therapy Market Drivers
Table 13. T-Cell Therapy Market Challenges
Table 14. T-Cell Therapy Market Restraints
Table 15. Global T-Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global T-Cell Therapy Market Share by Players (2020-2025)
Table 17. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2024)
Table 18. Ranking of Global Top T-Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by T-Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of T-Cell Therapy, Headquarters and Area Served
Table 21. Global Key Players of T-Cell Therapy, Product and Application
Table 22. Global Key Players of T-Cell Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global T-Cell Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global T-Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global T-Cell Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global T-Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global T-Cell Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global T-Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global T-Cell Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific T-Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific T-Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific T-Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Gilead Sciences, Inc. Company Details
Table 48. Gilead Sciences, Inc. Business Overview
Table 49. Gilead Sciences, Inc. T-Cell Therapy Product
Table 50. Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 51. Gilead Sciences, Inc. Recent Development
Table 52. Sorrento Therapeutics Company Details
Table 53. Sorrento Therapeutics Business Overview
Table 54. Sorrento Therapeutics T-Cell Therapy Product
Table 55. Sorrento Therapeutics Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 56. Sorrento Therapeutics Recent Development
Table 57. Fate Therapeutics Inc. Company Details
Table 58. Fate Therapeutics Inc. Business Overview
Table 59. Fate Therapeutics Inc. T-Cell Therapy Product
Table 60. Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 61. Fate Therapeutics Inc. Recent Development
Table 62. Novartis International AG Company Details
Table 63. Novartis International AG Business Overview
Table 64. Novartis International AG T-Cell Therapy Product
Table 65. Novartis International AG Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 66. Novartis International AG Recent Development
Table 67. AbbVie Inc. Company Details
Table 68. AbbVie Inc. Business Overview
Table 69. AbbVie Inc. T-Cell Therapy Product
Table 70. AbbVie Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 71. AbbVie Inc. Recent Development
Table 72. Adaptimmune Therapeutics PLC Company Details
Table 73. Adaptimmune Therapeutics PLC Business Overview
Table 74. Adaptimmune Therapeutics PLC T-Cell Therapy Product
Table 75. Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 76. Adaptimmune Therapeutics PLC Recent Development
Table 77. Bluebird Bio Company Details
Table 78. Bluebird Bio Business Overview
Table 79. Bluebird Bio T-Cell Therapy Product
Table 80. Bluebird Bio Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 81. Bluebird Bio Recent Development
Table 82. TCR2 Therapeutics, Inc. Company Details
Table 83. TCR2 Therapeutics, Inc. Business Overview
Table 84. TCR2 Therapeutics, Inc. T-Cell Therapy Product
Table 85. TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 86. TCR2 Therapeutics, Inc. Recent Development
Table 87. Pfizer Inc. Company Details
Table 88. Pfizer Inc. Business Overview
Table 89. Pfizer Inc. T-Cell Therapy Product
Table 90. Pfizer Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 91. Pfizer Inc. Recent Development
Table 92. DiaCarta, Inc. Company Details
Table 93. DiaCarta, Inc. Business Overview
Table 94. DiaCarta, Inc. T-Cell Therapy Product
Table 95. DiaCarta, Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)
Table 96. DiaCarta, Inc. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report


List of Figures
Figure 1. T-Cell Therapy Picture
Figure 2. Global T-Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global T-Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. CAR T Cell Therapy Features
Figure 5. TCR Therapy Features
Figure 6. TIL Therapy Features
Figure 7. Global T-Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global T-Cell Therapy Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics & Ambulatory Centers Case Studies
Figure 11. Cancer Research Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. T-Cell Therapy Report Years Considered
Figure 14. Global T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global T-Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global T-Cell Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global T-Cell Therapy Market Share by Players in 2024
Figure 18. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by T-Cell Therapy Revenue in 2024
Figure 20. North America T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America T-Cell Therapy Market Share by Country (2020-2031)
Figure 22. United States T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe T-Cell Therapy Market Share by Country (2020-2031)
Figure 26. Germany T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific T-Cell Therapy Market Share by Region (2020-2031)
Figure 34. China T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America T-Cell Therapy Market Share by Country (2020-2031)
Figure 42. Mexico T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa T-Cell Therapy Market Share by Country (2020-2031)
Figure 46. Turkey T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Gilead Sciences, Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 50. Sorrento Therapeutics Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 51. Fate Therapeutics Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 52. Novartis International AG Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 53. AbbVie Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 54. Adaptimmune Therapeutics PLC Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 55. Bluebird Bio Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 56. TCR2 Therapeutics, Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 57. Pfizer Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 58. DiaCarta, Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies